Prediction of Rehospitalization Following a Sepsis Admission Using a Wearable Biopatch

Part of paid clinical trials in San Diego, California.

Sponsor
University of California, San Diego
Study ID
NCT05806762
Status
Recruiting
Apply to this trial

Conditions

  • Sepsis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • BioIntellisense — DEVICE
    Enrolled patients will have a Fitbit placed on their wrist. There is no comparator group enrolled.

Study Details

The goal of this observational study is to learn about the utility of biopatches predicting 30-day readmissions in patients discharged from the hospital with sepsis. The main question\[s\] it aims to answer are: • Does the application of a biopatch provide data that can improve prediction of an unplanned 30-day readmission following a hospitalization for sepsis. Participants will be asked to wear a biopatch on their chest for 30-days following hospital discharge or until readmission to the hospital.

Key Dates

Start date
May 1, 2023
Status verified
Apr 2024
Primary completion
May 1, 2027
Completion
May 2, 2027

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Sepsis Patients Discharged From the Hospital
    We aim to apply a wearable biopatch to sepsis patients discharged from the hospital to determine if the additional data afforded by the biopatch can improve prediction of readmissions.

Primary Outcome Measure

Hospital readmission [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UC San Diego HealthSan DiegoCalifornia92103
Gabriel Wardi
[email protected]
619-543-6463

Find similar trials in San Diego, CA

By research site
UC San Diego Health· San Diego, CA

Related Studies